APONTIS PHARMA AG, DE000A3CMGM5

APONTIS PHARMA AG / DE000A3CMGM5

10.12.2024 - 15:56:17

APONTIS PHARMA AG: be executive GmbH, sell


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

10.12.2024 / 15:54 CET/CEST
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Name and legal form: be executive GmbH

2. Reason for the notification

a) Position / status
Person closely associated with:
Title:
First name: Bruno
Last name(s): Wohlschlegel
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
APONTIS PHARMA AG

b) LEI
894500ETO1J6MR8PDF91 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A3CMGM5

b) Nature of the transaction
Disposal

c) Price(s) and volume(s)
Price(s) Volume(s)
10.00 EUR 10000 EUR

d) Aggregated information
Price Aggregated volume
10.00 EUR 10000 EUR

e) Date of the transaction
04/12/2024; UTC+1

f) Place of the transaction
Outside a trading venue



10.12.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English
Company: APONTIS PHARMA AG
Rolf-Schwarz-Schütte-Platz 1
40789 Monheim am Rhein
Germany
Internet: https://apontis-pharma.de/

 
End of News EQS News Service

95791  10.12.2024 CET/CEST fncls.ssp?fn=show_t_gif&application_id=2048211&application_name=news&site_id=trading_house_net~~~7efceac5-959a-43d6-afef-21ad42b6a5d4
@ dgap.de